Burford Capital Limited has raised a further GBP100 million (approximately USD144 million) through an oversubscribed issue of bonds on the Main Market of the London Stock Exchange by Burford Capital PLC, its UK financing subsidiary. The bonds will pay interest at an annual rate of 6.125 per cent and
MedMen has closed a deal with global venture capital firm Cap-Meridian Ventures LTD (CMV). CMV has invested approximately USD15 million into MedMen. MedMen continues to rapidly expand its footprint in California on the heels of AB 243 and 266 (MMRSA) with a fully integrated presence. "We are excited with the
Preqin’s 2016 Sovereign Wealth Fund Review shows that, despite global market volatility and low oil prices, the AUM of sovereign wealth funds globally increased by USD200 billion over the previous year to reach USD6.51 trillion in March 2016. This growth was driven by non-commodity funds which added USD290 billion in
Ardian’s latest cycle of fundraising has attracted investment of USD14 billion, comprising USD10.8 billion from Ardian’s seventh generation secondary platform and USD3.2 billion of primary investments. This comes less than two years after Ardian raised USD10 billion through its previous round of fundraising. Ardian has now raised USD27.4 billion for
Monroe Capital has acted as sole lead arranger and administrative agent on a USD63 million senior credit facility to support an investment in Familia Dental Group Holdings (Familia) by private equity sponsor, The Halifax Group. Headquartered in suburban Chicago, Familia provides quality, affordable dental care to underserved populations in smaller
The Association of International Wealth Management of India (AIWMI), in conjunction with a number of big-name fund houses, has set up the Indian Association of Alternative Investment Funds (IAAIF). IAAIF aims to set standards and provides a voice for the emerging alternative investments sector in India. The current Charter Members
Ogier has assisted Medicxi Ventures, formerly Index Ventures Life Sciences, with its formation as an independent life sciences firm. Medicxi Ventures comprises all of the existing life sciences portfolio companies, funds and team from Index Ventures. The Ogier team also worked with Medicxi Ventures on the establishment of Medicxi Ventures
Quercus Assets Selection and Swiss Life Asset Managers have completed a deal to acquire Antin Solar Investments (ASI) in a 50:50 joint venture. ASI now operates as Azienda Solare Italiana Spa. On 18 December 2015 the joint venture, called Quercus Swiss Life Italian Solar Srl, had entered into a binding
Speyside Private Fund Advisers, a special situations buyout firm, has held the closing of Speyside Equity Fund I, a USD130 million buyout fund that will focus on investment opportunities in specialty chemicals, industrials/metal forming & food ingredients businesses and continue the disciplined investment approach that Speyside has successfully executed for
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management. This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval. G-Therapeutics (http://gtherapeutics.com/#About) develops
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
